Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beiyun Chen

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 27, 2019
Working Up Group 4 Equivocal HER2 Samples Tested by Fluorescence in Situ Hybridization in a Reference Laboratory Setting: Past, Present, and FutureKatherine B Geiersbach, Reid G Meyer, Daniel R Sill, et al.
Human Pathology|September 19, 2009
Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancerSejal S Shah, Rhett P Ketterling, Matthew P Goetz, et al.
Neoplasia (New York, N.Y.)|April 2, 2022
The breast tissue microbiome, stroma, immune cells and breast cancerTina J Hieken, Jun Chen, Beiyun Chen, et al.
American Journal of Clinical Pathology|January 21, 2012
Image analysis of HER2 immunohistochemical staining. Reproducibility and concordance with fluorescence in situ hybridization of a laboratory-validated scoring techniqueDouglas M Minot, Jesse Voss, Susan Rademacher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 29, 2012
Amyloidosis of the breast: predominantly AL type and over half have concurrent breast hematologic disordersSamar M Said, Carol Reynolds, Rafael E Jimenez, et al.
Human Pathology|October 24, 2002
Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphomaCyrus V Hedvat, Abhijith Hegde, Raju S k Chaganti, et al.
International Journal of Cancer|May 27, 2003
HER 2/neu expression and gene amplification in colon cancerDaniel R Nathanson, Alfred T Culliford, Jinru Shia, et al.
Archives of Pathology & Laboratory Medicine|October 28, 2020
HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ HybridizationKatherine B Geiersbach, Daniel R Sill, Reid G Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2017
IGF1R Protein Expression Is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2<sup>+</sup> Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831Monica M Reinholz, Beiyun Chen, Amylou C Dueck, et al.
Cancer|March 15, 2006
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosaRohit Bhargava, Beiyun Chen, David S Klimstra, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 27, 2019
Working Up Group 4 Equivocal HER2 Samples Tested by Fluorescence in Situ Hybridization in a Reference Laboratory Setting: Past, Present, and FutureKatherine B Geiersbach, Reid G Meyer, Daniel R Sill, et al.
Human Pathology|September 19, 2009
Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancerSejal S Shah, Rhett P Ketterling, Matthew P Goetz, et al.
Neoplasia (New York, N.Y.)|April 2, 2022
The breast tissue microbiome, stroma, immune cells and breast cancerTina J Hieken, Jun Chen, Beiyun Chen, et al.
American Journal of Clinical Pathology|January 21, 2012
Image analysis of HER2 immunohistochemical staining. Reproducibility and concordance with fluorescence in situ hybridization of a laboratory-validated scoring techniqueDouglas M Minot, Jesse Voss, Susan Rademacher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 29, 2012
Amyloidosis of the breast: predominantly AL type and over half have concurrent breast hematologic disordersSamar M Said, Carol Reynolds, Rafael E Jimenez, et al.
Human Pathology|October 24, 2002
Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphomaCyrus V Hedvat, Abhijith Hegde, Raju S k Chaganti, et al.
International Journal of Cancer|May 27, 2003
HER 2/neu expression and gene amplification in colon cancerDaniel R Nathanson, Alfred T Culliford, Jinru Shia, et al.
Archives of Pathology & Laboratory Medicine|October 28, 2020
HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ HybridizationKatherine B Geiersbach, Daniel R Sill, Reid G Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2017
IGF1R Protein Expression Is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2<sup>+</sup> Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831Monica M Reinholz, Beiyun Chen, Amylou C Dueck, et al.
Cancer|March 15, 2006
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosaRohit Bhargava, Beiyun Chen, David S Klimstra, et al.
Pageof 7